Severe familial cholestasis in North American Indian children: a clinical model of microfilament dysfunction?

Gastroenterology
|October 1, 1981
PubMed

Insights

Familial neonatal cholestasis in 14 children showed progressive liver damage and portal hypertension. This suggests a potential human model for microfilament dysfunction causing cholestasis.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Cell Biology

Background:

  • Severe neonatal cholestasis can lead to progressive liver damage.
  • Familial cholestasis presents unique challenges in diagnosis and management.
  • Understanding the cellular mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To describe clinical and pathological findings in North American Indian children with familial severe neonatal cholestasis.
  • To investigate the potential role of microfilament dysfunction in this condition.
  • To establish a potential human model for microfilament dysfunction-induced cholestasis.

Main Methods:

  • Clinical case series of 14 children with familial neonatal cholestasis.
  • Biochemical analysis including alkaline phosphatase, transaminases, and serum bile acids.
  • Histopathological examination (light and electron microscopy) of liver biopsies.
  • Immunofluorescence studies to detect cytoskeletal components.

Main Results:

  • Jaundice resolved in some neonates, but progressive liver damage, elevated serum bile acids, and pruritus persisted.
  • Seven children required portal-systemic shunts due to early portal hypertension and variceal bleeding.
  • Light microscopy revealed hepatitis with giant-cell transformation and biliary stasis, progressing to fibrosis and cirrhosis.
  • Electron microscopy showed dilated bile canaliculi with preserved microvilli and a prominent pericanalicular filamentous web.
  • Immunofluorescence confirmed the presence of actin-containing microfilaments.

Conclusions:

  • This cohort represents a potential human model for microfilament dysfunction-induced cholestasis.
  • Actin-containing microfilaments and their pericanalicular network are implicated in the cholestasis.
  • Further research into microfilament dynamics may offer therapeutic targets for neonatal cholestasis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...